Multi-Peptide Lash Serum: undeclared ingredient and sold without market authorization
Last updated
Summary
Product
Multi-Peptide Lash Serum
Issue
Health products - Product quality
Health products - Unauthorized product
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Multi-Peptide Lash Serum | Multi-Peptide Lash Serum | Not licensed | Liquid | Bimatoprost | 20221230 |
Issue
Affected lots contain an undeclared ingredient (bimatoprost). Product sold without market authorization (DIN) in Canada.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Linger Beauty
4974 Kingsway Ave, Box 425
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-74164
Get notified
Receive emails about new and updated recall and safety alerts.